# Deep Branch Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/deep-branch-biotechnology

- Industry: Biotechnology
- Headquarters: Nottingham, UK
- Website: www.deepbranch.com
- Total disclosed funding: $8.1M
- Latest round: Series A (Mar 11, 2021)
- Investors on record: 4

## About

Based in Nottingham, UK, Deep Branch Biotechnology Ltd. was founded in 2018 by co-founders Peter Rowe Ph.D, Robert Mansfield Ph.D, and Bart Pander Ph.D. The company is a carbon dioxide recycling firm that employs microorganisms to transform clean CO2 into high-quality goods for global animal feeding sustainability. The company as of Mach 2021 has a total of 3 funding rounds. The company operates in both the UK and the Netherlands.

Deep Branch method manufactures clean, nutritious, and sustainable single-cell protein directly from industrial waste gas carbon dioxide, allowing the feed sector to minimize its carbon footprint.

The company plans to complete its Scale-Up Hub, a production facility at the Brightlands Chemlot Campus in the Netherlands where the company will make the first pilot-scale batches of its Proton product. In 2023, the company will be scaling output and working together to finalize feed formulations for an anticipated 2023 market launch.

## Funding rounds

- Series A, Mar 11, 2021, $8.1M — DSM Venturing, Barclays Private Bank, Novo Holdings, Total Ventures

## Investors

- DSM Venturing (https://capitalatlas.ai/funds/dsm-venturing) — Series A
- Barclays Private Bank — Series A
- Novo Holdings — Series A
- Total Ventures (https://capitalatlas.ai/funds/total-ventures) — Series A